11 September 2023 - Health insurers mark up prices of generics for cancer, multiple sclerosis and other complicated diseases.
The cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55 a month. But many patients’ insurance plans are paying more than 100 times that.